Concepts (147)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Free Tissue Flaps | 10 | 2022 | 67 | 1.760 |
Why?
|
| Head and Neck Neoplasms | 13 | 2022 | 561 | 1.320 |
Why?
|
| Carcinoma, Squamous Cell | 5 | 2021 | 629 | 0.410 |
Why?
|
| Electrosurgery | 1 | 2010 | 15 | 0.370 |
Why?
|
| Sciatic Nerve | 1 | 2010 | 26 | 0.370 |
Why?
|
| Parotid Gland | 1 | 2010 | 33 | 0.370 |
Why?
|
| Facial Paralysis | 1 | 2010 | 25 | 0.360 |
Why?
|
| Parathyroid Glands | 1 | 2010 | 22 | 0.360 |
Why?
|
| Thyroid Gland | 1 | 2010 | 67 | 0.340 |
Why?
|
| Laryngectomy | 2 | 2020 | 30 | 0.340 |
Why?
|
| Laryngeal Neoplasms | 2 | 2020 | 47 | 0.340 |
Why?
|
| Body Image | 2 | 2020 | 100 | 0.330 |
Why?
|
| Parotid Neoplasms | 2 | 2017 | 49 | 0.230 |
Why?
|
| Mouth Neoplasms | 2 | 2021 | 206 | 0.200 |
Why?
|
| Xerostomia | 2 | 2013 | 24 | 0.200 |
Why?
|
| Middle Aged | 17 | 2021 | 21147 | 0.200 |
Why?
|
| Quality of Life | 2 | 2020 | 1515 | 0.200 |
Why?
|
| Aged | 14 | 2021 | 14862 | 0.200 |
Why?
|
| Retrospective Studies | 11 | 2022 | 7277 | 0.190 |
Why?
|
| Thigh | 2 | 2018 | 27 | 0.190 |
Why?
|
| Radiation Injuries | 2 | 2013 | 97 | 0.190 |
Why?
|
| Thyroid Diseases | 2 | 2011 | 33 | 0.190 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2021 | 87 | 0.190 |
Why?
|
| Cutaneous Fistula | 1 | 2020 | 11 | 0.180 |
Why?
|
| Pharyngeal Diseases | 1 | 2020 | 21 | 0.180 |
Why?
|
| Body Dysmorphic Disorders | 1 | 2020 | 13 | 0.180 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2021 | 446 | 0.180 |
Why?
|
| Transplant Donor Site | 1 | 2019 | 3 | 0.170 |
Why?
|
| Humans | 25 | 2022 | 68618 | 0.170 |
Why?
|
| Fibula | 1 | 2019 | 13 | 0.170 |
Why?
|
| Perforator Flap | 1 | 2019 | 10 | 0.170 |
Why?
|
| Vascularized Composite Allotransplantation | 1 | 2019 | 17 | 0.170 |
Why?
|
| Mouth | 1 | 2019 | 64 | 0.170 |
Why?
|
| Tongue Neoplasms | 1 | 2019 | 29 | 0.160 |
Why?
|
| Myocutaneous Flap | 1 | 2018 | 6 | 0.160 |
Why?
|
| Female | 17 | 2021 | 38074 | 0.160 |
Why?
|
| Salvage Therapy | 1 | 2018 | 82 | 0.160 |
Why?
|
| Fracture Fixation, Intramedullary | 1 | 2018 | 33 | 0.160 |
Why?
|
| Bone Transplantation | 1 | 2018 | 43 | 0.160 |
Why?
|
| Osteotomy | 1 | 2018 | 46 | 0.160 |
Why?
|
| Femur | 1 | 2018 | 113 | 0.150 |
Why?
|
| Cancer Survivors | 1 | 2020 | 146 | 0.150 |
Why?
|
| Microvessels | 1 | 2018 | 43 | 0.150 |
Why?
|
| Gastrostomy | 1 | 2018 | 110 | 0.150 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2018 | 62 | 0.150 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2017 | 49 | 0.150 |
Why?
|
| Male | 16 | 2021 | 37321 | 0.140 |
Why?
|
| Postoperative Care | 1 | 2017 | 163 | 0.140 |
Why?
|
| Surgical Wound Infection | 1 | 2018 | 168 | 0.140 |
Why?
|
| Early Goal-Directed Therapy | 1 | 2016 | 6 | 0.130 |
Why?
|
| Monitoring, Physiologic | 1 | 2017 | 219 | 0.130 |
Why?
|
| Postoperative Complications | 5 | 2022 | 1615 | 0.130 |
Why?
|
| Adult | 11 | 2020 | 21403 | 0.120 |
Why?
|
| Deglutition Disorders | 1 | 2018 | 297 | 0.120 |
Why?
|
| Treatment Outcome | 7 | 2021 | 7029 | 0.120 |
Why?
|
| Graft Survival | 1 | 2017 | 465 | 0.120 |
Why?
|
| Thyroidectomy | 2 | 2011 | 31 | 0.120 |
Why?
|
| Salivary Glands | 1 | 2013 | 52 | 0.110 |
Why?
|
| Prospective Studies | 3 | 2020 | 3705 | 0.110 |
Why?
|
| Telemedicine | 1 | 2020 | 700 | 0.100 |
Why?
|
| Internship and Residency | 1 | 2017 | 596 | 0.100 |
Why?
|
| Prognosis | 4 | 2019 | 2093 | 0.090 |
Why?
|
| Video-Assisted Surgery | 1 | 2010 | 6 | 0.090 |
Why?
|
| Neoplasm Staging | 2 | 2021 | 800 | 0.090 |
Why?
|
| Electrocoagulation | 1 | 2010 | 35 | 0.090 |
Why?
|
| Neck Dissection | 1 | 2010 | 55 | 0.090 |
Why?
|
| Thyroid Dysgenesis | 1 | 2010 | 1 | 0.090 |
Why?
|
| Recurrent Laryngeal Nerve | 1 | 2010 | 4 | 0.090 |
Why?
|
| Laryngeal Nerves | 1 | 2010 | 5 | 0.090 |
Why?
|
| Aged, 80 and over | 4 | 2017 | 4848 | 0.090 |
Why?
|
| Submandibular Gland | 1 | 2010 | 34 | 0.090 |
Why?
|
| Single-Blind Method | 1 | 2010 | 249 | 0.090 |
Why?
|
| Mast Cells | 1 | 2010 | 113 | 0.090 |
Why?
|
| Random Allocation | 1 | 2010 | 442 | 0.080 |
Why?
|
| Gestational Age | 1 | 2010 | 389 | 0.080 |
Why?
|
| Adolescent | 5 | 2020 | 8912 | 0.080 |
Why?
|
| Cohort Studies | 3 | 2021 | 2358 | 0.070 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2007 | 73 | 0.070 |
Why?
|
| Deglutition | 2 | 2019 | 221 | 0.070 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2010 | 2083 | 0.060 |
Why?
|
| Patient Satisfaction | 2 | 2020 | 378 | 0.060 |
Why?
|
| Pregnancy | 1 | 2010 | 2334 | 0.060 |
Why?
|
| Gentamicins | 1 | 2003 | 68 | 0.060 |
Why?
|
| Ear, Inner | 1 | 2003 | 47 | 0.060 |
Why?
|
| Meniere Disease | 1 | 2003 | 31 | 0.050 |
Why?
|
| Cost-Benefit Analysis | 2 | 2017 | 504 | 0.050 |
Why?
|
| Rats | 1 | 2010 | 5300 | 0.050 |
Why?
|
| Follow-Up Studies | 2 | 2019 | 3259 | 0.050 |
Why?
|
| Neck | 1 | 2022 | 62 | 0.050 |
Why?
|
| Combined Modality Therapy | 2 | 2019 | 951 | 0.050 |
Why?
|
| Neoadjuvant Therapy | 1 | 2021 | 104 | 0.050 |
Why?
|
| Antineoplastic Agents, Immunological | 1 | 2021 | 66 | 0.050 |
Why?
|
| Melanoma | 1 | 2005 | 335 | 0.050 |
Why?
|
| Time Factors | 2 | 2020 | 4655 | 0.050 |
Why?
|
| Pharyngectomy | 1 | 2020 | 3 | 0.050 |
Why?
|
| Diet | 2 | 2019 | 514 | 0.040 |
Why?
|
| Minimally Invasive Surgical Procedures | 2 | 2010 | 85 | 0.040 |
Why?
|
| Feeding Methods | 1 | 2019 | 17 | 0.040 |
Why?
|
| Survival Analysis | 1 | 2021 | 714 | 0.040 |
Why?
|
| Composite Tissue Allografts | 1 | 2019 | 8 | 0.040 |
Why?
|
| Case-Control Studies | 2 | 2018 | 1553 | 0.040 |
Why?
|
| Glossectomy | 1 | 2019 | 9 | 0.040 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2020 | 114 | 0.040 |
Why?
|
| Bone Nails | 1 | 2018 | 32 | 0.040 |
Why?
|
| Models, Anatomic | 1 | 2018 | 51 | 0.040 |
Why?
|
| Confidence Intervals | 1 | 2018 | 242 | 0.040 |
Why?
|
| Femoral Fractures | 1 | 2018 | 45 | 0.040 |
Why?
|
| Feasibility Studies | 1 | 2020 | 652 | 0.040 |
Why?
|
| Program Evaluation | 1 | 2020 | 502 | 0.040 |
Why?
|
| Surgical Flaps | 1 | 2018 | 120 | 0.040 |
Why?
|
| Operative Time | 1 | 2017 | 45 | 0.040 |
Why?
|
| Hospital Charges | 1 | 2017 | 60 | 0.040 |
Why?
|
| Bone Screws | 1 | 2018 | 90 | 0.040 |
Why?
|
| Ultrasonography, Doppler | 1 | 2017 | 57 | 0.040 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2021 | 756 | 0.040 |
Why?
|
| Biomechanical Phenomena | 1 | 2018 | 368 | 0.040 |
Why?
|
| Enteral Nutrition | 1 | 2018 | 157 | 0.040 |
Why?
|
| Anti-Bacterial Agents | 1 | 2003 | 1026 | 0.040 |
Why?
|
| Adaptation, Psychological | 1 | 2020 | 447 | 0.030 |
Why?
|
| Vascular Surgical Procedures | 1 | 2018 | 168 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2018 | 880 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2020 | 1342 | 0.030 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2020 | 468 | 0.030 |
Why?
|
| Length of Stay | 1 | 2017 | 780 | 0.030 |
Why?
|
| Intensive Care Units | 1 | 2016 | 344 | 0.030 |
Why?
|
| Animals | 1 | 2010 | 20881 | 0.030 |
Why?
|
| Hemodynamics | 1 | 2016 | 705 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2018 | 2007 | 0.030 |
Why?
|
| Thyroiditis | 1 | 2011 | 5 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2018 | 2279 | 0.020 |
Why?
|
| Cadaver | 1 | 2010 | 136 | 0.020 |
Why?
|
| Risk Factors | 1 | 2018 | 5731 | 0.020 |
Why?
|
| Mucous Membrane | 1 | 2005 | 66 | 0.020 |
Why?
|
| Sentinel Lymph Node Biopsy | 1 | 2005 | 53 | 0.020 |
Why?
|
| Cancer Vaccines | 1 | 2005 | 61 | 0.020 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2005 | 125 | 0.010 |
Why?
|
| Interleukin-2 | 1 | 2005 | 133 | 0.010 |
Why?
|
| Tympanic Membrane | 1 | 2003 | 25 | 0.010 |
Why?
|
| Survival Rate | 1 | 2007 | 1056 | 0.010 |
Why?
|
| Vertigo | 1 | 2003 | 24 | 0.010 |
Why?
|
| Administration, Topical | 1 | 2003 | 111 | 0.010 |
Why?
|
| Tinnitus | 1 | 2003 | 22 | 0.010 |
Why?
|
| Logistic Models | 1 | 2007 | 1420 | 0.010 |
Why?
|
| Hearing | 1 | 2003 | 133 | 0.010 |
Why?
|
| Life Style | 1 | 2005 | 338 | 0.010 |
Why?
|
| Young Adult | 1 | 2011 | 5717 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2003 | 931 | 0.010 |
Why?
|